Saltar para o conteúdo principal
  • Iniciar sessão
    Bem-vindo!
    A minha conta
    Terminar sessão

W. P. Carey Inc. (WPC) Stock Forecast 2025 - Previsão e análise de preços de IA

W. P. Carey Inc. (WPC) Previsão do preço das acções da AI e análise do investimento

W. P. Carey Inc. Gráfico de preços de acções e análise técnica

Carregando W. P. Carey Inc. gráfico interativo de preços e análise técnica...

W. P. Carey Inc. (WPC) - Análise exaustiva de acções e estudos de investimento

Deep dive into W. P. Carey Inc.'s business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about W. P. Carey Inc., including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

Para W. P. Carey Inc.: W. P. Carey Inc. operates in the Real Estate & Construction sector, positioning it as a large-cap market leader.

W. P. Carey Inc. (Símbolo da ação: WPC) é uma empresa líder no sector Real Estate & Construction , operando especificamente no sector Real Estate Investment Trusts.

A organização emprega aproximadamente 204 profissionais em todo o mundo .

A empresa estabeleceu-se como um importante líder de mercado com um apoio institucional significativo.

Understanding Financial Performance

O que significam estas métricas: Key financial indicators showing W. P. Carey Inc.'s revenue scale, profitability, market value, and shareholder returns.

Como os ler: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para W. P. Carey Inc.: With $1644M in annual revenue and 35,1% net margin, the company demonstrates exceptional profitability.

Receita anual: $1644 milhões gerar uma 35,1% margem de lucro líquida .

Capitalização de mercado: $14903 milhões - Classificado como acções de grande capitalização com estabilidade de nível institucional.

Rendimento do capital próprio (ROE): 7,1% - Abaixo da média eficiência da rendibilidade dos acionistas, indicando áreas de melhoria operacional.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for W. P. Carey Inc. stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

Para W. P. Carey Inc.: Unlock premium access to view detailed AI predictions and price targets.

🚀 Desbloquear previsões de IA Premium para aceder às nossas previsões avançadas de aprendizagem automática para as acções W. P. Carey Inc., incluindo objectivos de preço para 7 dias, 30 dias e 90 dias com intervalos de confiança e avaliações de risco.

Understanding Market Position

What this analysis covers: W. P. Carey Inc.'s competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

Para W. P. Carey Inc.: Strong free cash flow generation demonstrates solid operational efficiency.

W. P. Carey Inc. compete estrategicamente no mercado altamente dinâmico de Real Estate Investment Trusts mercado, posicionar-se como um líder de mercado dominante de grande capitalização, com vantagens competitivas significativas e confiança dos investidores institucionais .

A empresa demonstra uma eficiência operacional robusta através de uma forte geração de fluxo de caixa livre de $974 milhões por ano, complementado por um impressionante crescimento do fluxo de tesouraria -1,3% ano após ano.

A empresa mantém uma margem bruta 53,4% saudável, o que indica um forte poder de fixação de preços e eficiência operacional.

W. P. Carey Inc. (WPC) Análise fundamental e dados sobre transacções com informações privilegiadas (Relatórios financeiros trimestrais)

Dados financeiros trimestrais abrangentes, tendências de ganhos, transacções com informação privilegiada e participações institucionais para W. P. Carey Inc. análise de acções.

Carregando W. P. Carey Inc. análise fundamental abrangente e dados de informações privilegiadas...

Mergulhe profundamente na saúde financeira de W. P. Carey Inc., nas métricas de avaliação e na eficiência operacional para tomar decisões de investimento informadas.

Compreender as métricas de avaliação

O que significam estas métricas: Os indicadores de avaliação ajudam a determinar se as acções W. P. Carey Inc. estão a um preço justo em comparação com os seus ganhos, activos e posição no mercado.

Como os ler: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

Para W. P. Carey Inc.: Com um rácio P/E de 44,38, o mercado valoriza muito as perspectivas de crescimento futuro.

P/E Ratio 44,38x
P/B Ratio 1,81x
Market Cap $14903M
Dividend Yield 5,26%
EPS $1,52
Valor contabilístico/ação $37,11
Receitas/participações $7,43
FCF/Ação $4,54
Compreender os indicadores de rentabilidade

O que significam estas métricas: Estes rácios medem a eficiência com que W. P. Carey Inc. converte as receitas em lucros e gera retorno para os acionistas.

Como os ler: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

Para W. P. Carey Inc.: Um ROE de 7,1% indica que há margem para melhorias em criação de valor para os acionistas.

ROE 7,1%
ROA 3,4%
ROIC 5,0%
Gross Margin 53,4%
Operating Margin 47,4%
Net Margin 35,1%
EBT Margin 39,8%
Tax Rate 5,5%
Compreender os indicadores de saúde financeira

O que significam estas métricas: Estes rácios avaliam a capacidade da W. P. Carey Inc. para cumprir as obrigações a curto prazo e gerir eficazmente os níveis de endividamento.

Como os ler: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

Para W. P. Carey Inc.: Um rácio atual de 0,28 sugere potenciais problemas de liquidez.

Current Ratio 0,28x
Quick Ratio 0,28x
D/E Ratio 0,88x
Financial Leverage 2,02x
Interest Coverage 3,9x
Working Capital $-497M
Compreender a métrica do fluxo de caixa

O que significam estas métricas: Os indicadores do fluxo de tesouraria revelam a capacidade da W. P. Carey Inc. para gerar fundos a partir das operações e financiar iniciativas de crescimento.

Como os ler: Um fluxo de caixa operacional positivo é crucial. O fluxo de caixa livre mostra o dinheiro disponível para dividendos, recompras ou investimentos.

Para W. P. Carey Inc.: Fluxo de caixa livre de $974M proporciona flexibilidade para o retorno dos acionistas e investimentos de crescimento.

Operating Cash Flow $974M
Free Cash Flow $974M
Capital Spending $-15M
OCF Growth YoY -1,3%
FCF Growth YoY -1,3%
FCF/Sales 71,2%
CapEx/Sales 1,8%
Compreender os indicadores de eficiência operacional

O que significam estas métricas: Estes rácios medem a eficácia com que W. P. Carey Inc. utiliza os seus activos e gere o capital de exploração.

Como os ler: Rácios de rotação mais elevados indicam uma utilização eficiente dos activos. Períodos de cobrança mais curtos revelam uma gestão eficaz do crédito.

Para W. P. Carey Inc.: Um volume de negócios do ativo de 0,09x sugere que há margem para melhorias em utilização de activos.

Asset Turnover 0,09x
Receivables Turnover 2012,9x
Fixed Assets Turnover 0,6x
Dias de vendas pendentes 0 dias
Período de contas a pagar 1675 dias
Compreender os dados do balanço financeiro

O que significam estas métricas: Índices da demonstração de resultados e do balanço de W. P. Carey Inc. que mostram o desempenho financeiro absoluto.

Como os ler: As receitas mostram a escala do negócio, enquanto as margens indicam a rendibilidade. As rubricas do balanço revelam a estrutura financeira.

Para W. P. Carey Inc.: Com uma receita anual de $1644M, W. P. Carey Inc. opera a uma escala significativa.

Demonstração de resultados ($ Milhões de euros)
Receitas totais $1644M
Receitas operacionais $648M
Despesas VAG $8M
Custo das mercadorias vendidas $9M
Destaques do balanço (% Of Assets)
Total Current Assets 1%
Cash & Short-term Investments 1%
Total Liabilities 51%
Short-term Debt 16%
Accounts Receivable 0%
Informação sobre dividendos e acionistas
Dividends Per Share $3,54
Payout Ratio 2,3%
Shares Outstanding 221M
Métricas de crescimento (YoY)
EPS Growth 0,9%

Mais recentes W. P. Carey Inc. Notícias sobre acções e análise de mercado

Notícias de última hora, relatórios de analistas e actualizações de mercado que afectam o preço das acções da W. P. Carey Inc. (WPC) e as perspectivas de investimento.

📰 Estamos atualmente a atualizar o nosso feed de notícias para W. P. Carey Inc.. Volte em breve para obter as últimas análises de mercado e actualizações da empresa.

W. P. Carey Inc. Concorrentes e análise dos pares - Real Estate & Construction Setor

Análise comparativa de W. P. Carey Inc. em relação aos seus pares e concorrentes no sector Real Estate & Construction, com previsões baseadas em IA e principais métricas financeiras.

Empresa Símbolo do Ticker Previsão de IA a 90 dias Capitalização bolsista (USD M) Rácio P/E Rácio P/B
AAT Unlock Forecast - 30 Days FREE Trial $1499M 15,9x 1,3x
ABR Unlock Forecast - 30 Days FREE Trial $2590M 12,1x 0,9x
ABR-PD Unlock Forecast - 30 Days FREE Trial $3979M 18,6x 1,3x
ABR-PE Unlock Forecast - 30 Days FREE Trial $3935M 18,4x 1,3x
ABR-PF Unlock Forecast - 30 Days FREE Trial $4866M 22,8x 1,6x
ACR Unlock Forecast - 30 Days FREE Trial $159M 7,3x 0,4x
ACRE Unlock Forecast - 30 Days FREE Trial $282M 8,5x 0,5x
ACR-PC Unlock Forecast - 30 Days FREE Trial $191M 8,8x 0,5x
ACR-PD Unlock Forecast - 30 Days FREE Trial $167M 7,7x 0,4x
ADC Unlock Forecast - 30 Days FREE Trial $8037M 43,3x 1,4x
ADC-PA Unlock Forecast - 30 Days FREE Trial $2010M 10,8x 0,4x
AGNC Unlock Forecast - 30 Days FREE Trial $10771M 28,5x 1,0x
AGNCL Unlock Forecast - 30 Days FREE Trial $26376M 69,8x 2,6x
AGNCM Unlock Forecast - 30 Days FREE Trial $26043M 68,9x 2,5x
AGNCN Unlock Forecast - 30 Days FREE Trial $26824M 71,0x 2,6x
AGNCO Unlock Forecast - 30 Days FREE Trial $26688M 70,6x 2,6x
AGNCP Unlock Forecast - 30 Days FREE Trial $26230M 69,4x 2,5x
AHR Unlock Forecast - 30 Days FREE Trial $6933M x 2,9x
AHT Unlock Forecast - 30 Days FREE Trial $19M -1,5x -0,1x
AHT-PD Unlock Forecast - 30 Days FREE Trial $54M x x
AHT-PF Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PG Unlock Forecast - 30 Days FREE Trial $51M x x
AHT-PH Unlock Forecast - 30 Days FREE Trial $45M x x
AHT-PI Unlock Forecast - 30 Days FREE Trial $45M x x
AIV Unlock Forecast - 30 Days FREE Trial $3249M -6,0x 35,5x
AJX Unlock Forecast - 30 Days FREE Trial $133M -0,8x 0,5x
AKR Unlock Forecast - 30 Days FREE Trial $2429M 470,2x 1,1x
ALEX Unlock Forecast - 30 Days FREE Trial $1367M 17,5x 1,4x
ALX Unlock Forecast - 30 Days FREE Trial $1218M 32,6x 8,4x
AMH Unlock Forecast - 30 Days FREE Trial $332M 39,2x 0,1x
AMT Unlock Forecast - 30 Days FREE Trial $256165M 198,2x 69,0x
APLE Unlock Forecast - 30 Days FREE Trial $3048M 16,8x 1,0x
ARE Unlock Forecast - 30 Days FREE Trial $18446M 55,8x 1,1x
ARI Unlock Forecast - 30 Days FREE Trial $1529M -9,0x 0,8x
ARR Unlock Forecast - 30 Days FREE Trial $1379M -6,0x 0,8x
ARR-PC Unlock Forecast - 30 Days FREE Trial $1909M x 1,2x
AVB Unlock Forecast - 30 Days FREE Trial $28305M 24,4x 2,4x
BDN Unlock Forecast - 30 Days FREE Trial $764M -5,2x 0,9x
BFS Unlock Forecast - 30 Days FREE Trial $1204M 28,0x 3,7x
BFS-PD Unlock Forecast - 30 Days FREE Trial $826M 19,2x 2,6x
BFS-PE Unlock Forecast - 30 Days FREE Trial $870M 20,2x 2,7x
BHM Unlock Forecast - 30 Days FREE Trial $227M 83,0x 1,7x
BHR Unlock Forecast - 30 Days FREE Trial $597M -3,1x 2,7x
BHR-PB Unlock Forecast - 30 Days FREE Trial $3269M x 14,5x
BHR-PD Unlock Forecast - 30 Days FREE Trial $4058M x 18,0x
BMNM Unlock Forecast - 30 Days FREE Trial $14M x 0,6x
BNL Unlock Forecast - 30 Days FREE Trial $3814M 38,6x 1,3x
BRSP Unlock Forecast - 30 Days FREE Trial $751M -6,6x 0,8x
BRT Unlock Forecast - 30 Days FREE Trial $282M -37,6x 1,5x
BRX Unlock Forecast - 30 Days FREE Trial $8544M 25,5x 2,9x
BXMT Unlock Forecast - 30 Days FREE Trial $3301M -17,4x 0,9x
BXP Unlock Forecast - 30 Days FREE Trial $17966M 3640,5x 3,4x
CBL Unlock Forecast - 30 Days FREE Trial $950M 14,5x 3,3x
CCI Unlock Forecast - 30 Days FREE Trial $46333M 36,6x 6,1x
CDP Unlock Forecast - 30 Days FREE Trial $3615M 24,1x 2,4x
CDR-PB Unlock Forecast - 30 Days FREE Trial $244M 44,3x 10,9x
CDR-PC Unlock Forecast - 30 Days FREE Trial $220M 39,8x 9,8x
CHCT Unlock Forecast - 30 Days FREE Trial $443M -220,9x 1,0x
CHMI Unlock Forecast - 30 Days FREE Trial $106M -9,3x 0,5x
CHMI-PA Unlock Forecast - 30 Days FREE Trial $842M x 3,7x
CHMI-PB Unlock Forecast - 30 Days FREE Trial $882M x 3,8x
CHTH Unlock Forecast - 30 Days FREE Trial $603M x 0,9x
CIM Unlock Forecast - 30 Days FREE Trial $1195M 6,2x 0,5x
CIMN Unlock Forecast - 30 Days FREE Trial $2081M 10,8x 0,8x
CIMO Unlock Forecast - 30 Days FREE Trial $2091M 10,9x 0,8x
CIM-PA Unlock Forecast - 30 Days FREE Trial $1862M 9,7x 0,7x
CIM-PB Unlock Forecast - 30 Days FREE Trial $2005M 10,4x 0,8x
CIM-PC Unlock Forecast - 30 Days FREE Trial $1915M 9,9x 0,7x
CIM-PD Unlock Forecast - 30 Days FREE Trial $1995M 10,4x 0,8x
CIO Unlock Forecast - 30 Days FREE Trial $280M -15,4x 0,5x
CIO-PA Unlock Forecast - 30 Days FREE Trial $1010M x 1,6x
CLDT Unlock Forecast - 30 Days FREE Trial $388M 41,0x 0,5x
CLDT-PA Unlock Forecast - 30 Days FREE Trial $1101M 116,5x 1,5x
CLPR Unlock Forecast - 30 Days FREE Trial $73M -10,4x -20,5x
CMCT Unlock Forecast - 30 Days FREE Trial $6M -0,1x 0,0x
CMRF Unlock Forecast - 30 Days FREE Trial $1241M x 0,7x
COLD Unlock Forecast - 30 Days FREE Trial $3902M -26,5x 1,3x
CPT Unlock Forecast - 30 Days FREE Trial $12240M 78,5x 2,7x
CSR Unlock Forecast - 30 Days FREE Trial $1189M -74,6x 1,7x
CTO Unlock Forecast - 30 Days FREE Trial $574M 41,8x 1,0x
CTO-PA Unlock Forecast - 30 Days FREE Trial $730M x 1,3x
CTRE Unlock Forecast - 30 Days FREE Trial $6938M 31,6x 2,1x
CUBE Unlock Forecast - 30 Days FREE Trial $9688M 25,9x 3,4x
CUZ Unlock Forecast - 30 Days FREE Trial $4927M 81,8x 1,0x
CXW Unlock Forecast - 30 Days FREE Trial $2189M 21,0x 1,5x
DEA Unlock Forecast - 30 Days FREE Trial $1029M 65,3x 0,8x
DEI Unlock Forecast - 30 Days FREE Trial $4888M 129,7x 2,4x
DHC Unlock Forecast - 30 Days FREE Trial $1033M -1,7x 0,6x
DHCNI Unlock Forecast - 30 Days FREE Trial $4225M -10,4x 2,3x
DHCNL Unlock Forecast - 30 Days FREE Trial $3981M x 2,0x
DLR Unlock Forecast - 30 Days FREE Trial $60397M 43,7x 2,6x
DLR-PJ Unlock Forecast - 30 Days FREE Trial $8355M 6,0x 0,4x
DLR-PK Unlock Forecast - 30 Days FREE Trial $9314M 6,7x 0,4x
DLR-PL Unlock Forecast - 30 Days FREE Trial $8104M 5,9x 0,4x
DOC Unlock Forecast - 30 Days FREE Trial $13818M 83,8x 1,7x
DRH Unlock Forecast - 30 Days FREE Trial $1764M 26,0x 1,1x
DRH-PA Unlock Forecast - 30 Days FREE Trial $5413M 79,8x 3,4x
DTLAP Unlock Forecast - 30 Days FREE Trial $0M x x
DX Unlock Forecast - 30 Days FREE Trial $1376M 41,8x 1,8x
DX-PC Unlock Forecast - 30 Days FREE Trial $M x x
EARN Unlock Forecast - 30 Days FREE Trial $212M -11,6x 0,9x
EGP Unlock Forecast - 30 Days FREE Trial $8798M 37,2x 2,6x
ELME Unlock Forecast - 30 Days FREE Trial $1514M -114,5x 1,5x
ELS Unlock Forecast - 30 Days FREE Trial $12904M 25,8x 7,5x
EPR Unlock Forecast - 30 Days FREE Trial $0M 18,4x 0,0x
EPR-PC Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PE Unlock Forecast - 30 Days FREE Trial $M x x
EPR-PG Unlock Forecast - 30 Days FREE Trial $M x x
EPRT Unlock Forecast - 30 Days FREE Trial $6048M 27,0x 1,6x
EQC Unlock Forecast - 30 Days FREE Trial $177M 2,3x 0,1x
EQIX Unlock Forecast - 30 Days FREE Trial $75118M 75,6x 5,3x
EQR Unlock Forecast - 30 Days FREE Trial $25472M 28,0x 2,3x
ESRT Unlock Forecast - 30 Days FREE Trial $0M 52,3x 0,0x
ESS Unlock Forecast - 30 Days FREE Trial $17731M 22,2x 3,2x
EXR Unlock Forecast - 30 Days FREE Trial $33211M 34,0x 2,4x
FBRT Unlock Forecast - 30 Days FREE Trial $1025M 9,4x 0,7x
FBRT-PE Unlock Forecast - 30 Days FREE Trial $1885M 17,2x 1,3x
FCPT Unlock Forecast - 30 Days FREE Trial $2656M 25,1x 1,8x
FPI Unlock Forecast - 30 Days FREE Trial $521M 53,4x 0,8x
FR Unlock Forecast - 30 Days FREE Trial $7141M 26,3x 2,7x
FREVS Unlock Forecast - 30 Days FREE Trial $0M 0,0x 0,0x
FRT Unlock Forecast - 30 Days FREE Trial $9463M 27,3x 2,9x
FRT-PC Unlock Forecast - 30 Days FREE Trial $1959M 5,7x 0,6x
FSP Unlock Forecast - 30 Days FREE Trial $174M -1,9x 0,3x
FVR Unlock Forecast - 30 Days FREE Trial $508M x 1,4x
GIPR Unlock Forecast - 30 Days FREE Trial $-118M -0,8x 17,0x
GIPRW Unlock Forecast - 30 Days FREE Trial $1M x 0,2x
GLPI Unlock Forecast - 30 Days FREE Trial $14692M 20,5x 3,2x
GMRE Unlock Forecast - 30 Days FREE Trial $527M 51,2x 1,1x
GMRE-PA Unlock Forecast - 30 Days FREE Trial $1761M 171,1x 3,5x
GNL Unlock Forecast - 30 Days FREE Trial $1622M -4,5x 0,9x
GPMT Unlock Forecast - 30 Days FREE Trial $146M -0,9x 0,3x
GPMT-PA Unlock Forecast - 30 Days FREE Trial $985M x 1,7x
GRP-UN Unlock Forecast - 30 Days FREE Trial $2657M x 3,0x
HHH Unlock Forecast - 30 Days FREE Trial $3476M -4,8x 1,3x
HIW Unlock Forecast - 30 Days FREE Trial $3611M 27,5x 1,5x
HR Unlock Forecast - 30 Days FREE Trial $5686M -11,5x 1,1x
HST Unlock Forecast - 30 Days FREE Trial $12369M 18,8x 1,9x
HTIA Unlock Forecast - 30 Days FREE Trial $414M -7,6x 0,6x
HTIBP Unlock Forecast - 30 Days FREE Trial $405M -7,3x 0,6x
ICRP Unlock Forecast - 30 Days FREE Trial $81M 7,2x 0,3x
ICR-PA Unlock Forecast - 30 Days FREE Trial $196M 17,3x 0,8x
IHT Unlock Forecast - 30 Days FREE Trial $2M -57,7x 0,6x
ILPT Unlock Forecast - 30 Days FREE Trial $744M -2,3x 1,4x
IMPM Unlock Forecast - 30 Days FREE Trial $2M x x
INN Unlock Forecast - 30 Days FREE Trial $903M 104,9x 1,0x
INN-PE Unlock Forecast - 30 Days FREE Trial $3414M 396,4x 3,8x
INN-PF Unlock Forecast - 30 Days FREE Trial $3372M 391,5x 3,8x
IOR Unlock Forecast - 30 Days FREE Trial $75M 12,5x 0,6x
IRET Unlock Forecast - 30 Days FREE Trial $317M 16,7x 0,5x
IRM Unlock Forecast - 30 Days FREE Trial $29130M 202,7x -41,7x
IRT Unlock Forecast - 30 Days FREE Trial $4340M 156,4x 1,3x
IVR Unlock Forecast - 30 Days FREE Trial $529M 13,1x 0,8x
IVR-PC Unlock Forecast - 30 Days FREE Trial $1632M 40,3x 2,3x
IVT Unlock Forecast - 30 Days FREE Trial $2300M 20,5x 1,3x
JBGS Unlock Forecast - 30 Days FREE Trial $1327M -11,3x 0,7x
KBSR Unlock Forecast - 30 Days FREE Trial $21M x 0,1x
KIM Unlock Forecast - 30 Days FREE Trial $15537M 26,0x 1,5x
KIM-PL Unlock Forecast - 30 Days FREE Trial $14826M 24,8x 1,4x
KIM-PM Unlock Forecast - 30 Days FREE Trial $15178M 25,4x 1,4x
KIM-PN Unlock Forecast - 30 Days FREE Trial $41959M 70,2x 4,0x
KRC Unlock Forecast - 30 Days FREE Trial $5280M 24,1x 1,0x
KREF Unlock Forecast - 30 Days FREE Trial $700M 952,5x 0,6x
KREF-PA Unlock Forecast - 30 Days FREE Trial $1409M x 1,1x
KRG Unlock Forecast - 30 Days FREE Trial $5176M 27,7x 1,6x
LADR Unlock Forecast - 30 Days FREE Trial $0M 15,1x 0,0x
LAMR Unlock Forecast - 30 Days FREE Trial $13138M 29,9x 14,5x
LAND Unlock Forecast - 30 Days FREE Trial $373M -54,4x 0,5x
LANDM Unlock Forecast - 30 Days FREE Trial $900M -119,7x 1,3x
LANDO Unlock Forecast - 30 Days FREE Trial $723M -104,0x 1,1x
LANDP Unlock Forecast - 30 Days FREE Trial $722M -103,5x 1,1x
LFT Unlock Forecast - 30 Days FREE Trial $122M 8,6x 0,5x
LFT-PA Unlock Forecast - 30 Days FREE Trial $1131M 79,4x 4,9x
LINE Unlock Forecast - 30 Days FREE Trial $10231M x 1,2x
LOAN Unlock Forecast - 30 Days FREE Trial $62M 11,2x 1,4x
LTC Unlock Forecast - 30 Days FREE Trial $1838M 22,1x 1,9x
LXP Unlock Forecast - 30 Days FREE Trial $2709M 31,0x 1,3x
LXP-PC Unlock Forecast - 30 Days FREE Trial $14076M 160,9x 6,8x
MAA Unlock Forecast - 30 Days FREE Trial $17518M 30,6x 3,0x
MAA-PI Unlock Forecast - 30 Days FREE Trial $6948M 12,2x 1,2x
MAC Unlock Forecast - 30 Days FREE Trial $4827M -64,7x 1,9x
MDRR Unlock Forecast - 30 Days FREE Trial $15M -8,9x 1,1x
MDRRP Unlock Forecast - 30 Days FREE Trial $28M -16,5x 2,3x
MDV Unlock Forecast - 30 Days FREE Trial $219M -24,6x 1,3x
MDV-PA Unlock Forecast - 30 Days FREE Trial $364M x 2,2x
MFA Unlock Forecast - 30 Days FREE Trial $1089M 8,5x 0,6x
MFAN Unlock Forecast - 30 Days FREE Trial $2651M 20,6x 1,5x
MFAO Unlock Forecast - 30 Days FREE Trial $2662M 20,7x 1,5x
MFA-PB Unlock Forecast - 30 Days FREE Trial $2288M 17,8x 1,3x
MFA-PC Unlock Forecast - 30 Days FREE Trial $2552M 19,9x 1,4x
MITN Unlock Forecast - 30 Days FREE Trial $757M 16,3x 1,4x
MITP Unlock Forecast - 30 Days FREE Trial $753M 16,2x 1,4x
MITT Unlock Forecast - 30 Days FREE Trial $232M 5,0x 0,4x
MITT-PA Unlock Forecast - 30 Days FREE Trial $685M 14,8x 1,3x
MITT-PB Unlock Forecast - 30 Days FREE Trial $672M 14,5x 1,3x
MITT-PC Unlock Forecast - 30 Days FREE Trial $750M 16,2x 1,4x
MKZR Unlock Forecast - 30 Days FREE Trial $133M x 2,0x
MPW Unlock Forecast - 30 Days FREE Trial $2719M -1,3x 0,6x
NHHS Unlock Forecast - 30 Days FREE Trial $340M 3,0x 1,4x
NHI Unlock Forecast - 30 Days FREE Trial $3682M 25,8x 2,5x
NHPAP Unlock Forecast - 30 Days FREE Trial $452M x 0,7x
NHPBP Unlock Forecast - 30 Days FREE Trial $454M x 0,7x
NLCP Unlock Forecast - 30 Days FREE Trial $292M 11,2x 0,7x
NLOP Unlock Forecast - 30 Days FREE Trial $439M x 0,9x
NLY Unlock Forecast - 30 Days FREE Trial $13285M -22,9x 1,0x
NNN Unlock Forecast - 30 Days FREE Trial $8095M 20,6x 1,9x
NREF Unlock Forecast - 30 Days FREE Trial $269M -28,2x 2,5x
NREF-PA Unlock Forecast - 30 Days FREE Trial $M x x
NSA Unlock Forecast - 30 Days FREE Trial $2861M 26,1x 2,8x
NTST Unlock Forecast - 30 Days FREE Trial $1549M 1247,7x 1,2x
NXDT Unlock Forecast - 30 Days FREE Trial $181M -1,9x 0,2x
NXDT-PA Unlock Forecast - 30 Days FREE Trial $681M x 0,9x
NXRT Unlock Forecast - 30 Days FREE Trial $880M 16,6x 2,5x
NYC Unlock Forecast - 30 Days FREE Trial $35M -0,1x 0,5x
NYMT Unlock Forecast - 30 Days FREE Trial $684M 11,0x 0,5x
NYMTG Unlock Forecast - 30 Days FREE Trial $2313M 37,2x 1,7x
NYMTI Unlock Forecast - 30 Days FREE Trial $2322M 37,4x 1,7x
NYMTL Unlock Forecast - 30 Days FREE Trial $2059M 33,1x 1,5x
NYMTM Unlock Forecast - 30 Days FREE Trial $2315M 37,3x 1,7x
NYMTN Unlock Forecast - 30 Days FREE Trial $2003M 32,2x 1,5x
NYMTZ Unlock Forecast - 30 Days FREE Trial $1660M 26,7x 1,2x
O Unlock Forecast - 30 Days FREE Trial $54324M 59,3x 1,4x
OHI Unlock Forecast - 30 Days FREE Trial $10939M 27,3x 2,3x
OLP Unlock Forecast - 30 Days FREE Trial $501M 25,4x 1,7x
ONL Unlock Forecast - 30 Days FREE Trial $170M -2,5x 0,2x
ORC Unlock Forecast - 30 Days FREE Trial $911M 142,2x 1,0x
OUT Unlock Forecast - 30 Days FREE Trial $4003M 37,2x 7,4x
PCH Unlock Forecast - 30 Days FREE Trial $3331M 80,0x 1,7x
PCOK Unlock Forecast - 30 Days FREE Trial $180M x 5,5x
PEB Unlock Forecast - 30 Days FREE Trial $1400M -21,5x 0,5x
PEB-PE Unlock Forecast - 30 Days FREE Trial $2468M x 0,9x
PEB-PF Unlock Forecast - 30 Days FREE Trial $2532M x 1,0x
PEB-PG Unlock Forecast - 30 Days FREE Trial $2464M x 0,9x
PEB-PH Unlock Forecast - 30 Days FREE Trial $2230M x 0,8x
PECO Unlock Forecast - 30 Days FREE Trial $5626M 81,7x 2,5x
PGRE Unlock Forecast - 30 Days FREE Trial $1392M -5,8x 0,5x
PINE Unlock Forecast - 30 Days FREE Trial $265M 169,3x 1,2x
PKST Unlock Forecast - 30 Days FREE Trial $518M -3,7x 0,7x
PLD Unlock Forecast - 30 Days FREE Trial $116289M 33,7x 2,2x
PLDGP Unlock Forecast - 30 Days FREE Trial $58098M 16,9x 1,1x
PLYM Unlock Forecast - 30 Days FREE Trial $705M 59,5x 1,2x
PMT Unlock Forecast - 30 Days FREE Trial $1079M 10,3x 0,6x
PMT-PA Unlock Forecast - 30 Days FREE Trial $2111M 20,1x 1,1x
PMT-PB Unlock Forecast - 30 Days FREE Trial $2094M 19,9x 1,1x
PMT-PC Unlock Forecast - 30 Days FREE Trial $1630M 15,5x 0,9x
PMTU Unlock Forecast - 30 Days FREE Trial $2221M 21,1x 1,2x
PMTV Unlock Forecast - 30 Days FREE Trial $2213M 21,0x 1,2x
PMTW Unlock Forecast - 30 Days FREE Trial $2206M 21,0x 1,2x
PSA Unlock Forecast - 30 Days FREE Trial $52425M 29,0x 5,6x
PSA-PF Unlock Forecast - 30 Days FREE Trial $3883M 2,1x 0,4x
PSA-PG Unlock Forecast - 30 Days FREE Trial $3791M 2,1x 0,4x
PSA-PH Unlock Forecast - 30 Days FREE Trial $4228M 2,3x 0,5x
PSA-PI Unlock Forecast - 30 Days FREE Trial $3583M 2,0x 0,4x
PSA-PJ Unlock Forecast - 30 Days FREE Trial $3469M 1,9x 0,4x
PSA-PK Unlock Forecast - 30 Days FREE Trial $3552M 2,0x 0,4x
PSA-PL Unlock Forecast - 30 Days FREE Trial $3421M 1,9x 0,4x
PSA-PM Unlock Forecast - 30 Days FREE Trial $3052M 1,7x 0,3x
PSA-PN Unlock Forecast - 30 Days FREE Trial $2864M 1,6x 0,3x
PSA-PO Unlock Forecast - 30 Days FREE Trial $2883M 1,6x 0,3x
PSA-PP Unlock Forecast - 30 Days FREE Trial $2953M 1,6x 0,3x
PSA-PQ Unlock Forecast - 30 Days FREE Trial $2903M 1,6x 0,3x
PSA-PR Unlock Forecast - 30 Days FREE Trial $2955M 1,6x 0,3x
PSA-PS Unlock Forecast - 30 Days FREE Trial $3031M 1,7x 0,3x
PSTL Unlock Forecast - 30 Days FREE Trial $0M 147,2x 0,0x
PW Unlock Forecast - 30 Days FREE Trial $3M -0,2x 0,6x
PW-PA Unlock Forecast - 30 Days FREE Trial $13M x 2,1x
RC Unlock Forecast - 30 Days FREE Trial $769M -13,0x 0,4x
RCB Unlock Forecast - 30 Days FREE Trial $4373M -44,3x 2,4x
RCC Unlock Forecast - 30 Days FREE Trial $4448M -45,2x 2,4x
RCD Unlock Forecast - 30 Days FREE Trial $4253M x 2,3x
RC-PC Unlock Forecast - 30 Days FREE Trial $2970M x 1,6x
RC-PE Unlock Forecast - 30 Days FREE Trial $2848M x 1,6x
REFI Unlock Forecast - 30 Days FREE Trial $279M 8,1x 0,9x
REG Unlock Forecast - 30 Days FREE Trial $13312M 22,1x 2,0x
REGCO Unlock Forecast - 30 Days FREE Trial $4284M x 0,6x
REGCP Unlock Forecast - 30 Days FREE Trial $4392M x 0,7x
REXR Unlock Forecast - 30 Days FREE Trial $10585M 33,3x 1,2x
REXR-PB Unlock Forecast - 30 Days FREE Trial $5664M 17,8x 0,6x
REXR-PC Unlock Forecast - 30 Days FREE Trial $5650M 17,8x 0,6x
RHP Unlock Forecast - 30 Days FREE Trial $10080M 37,7x 12,6x
RITM Unlock Forecast - 30 Days FREE Trial $6987M 8,7x 0,9x
RITM-PA Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PB Unlock Forecast - 30 Days FREE Trial $14226M 17,7x 1,8x
RITM-PC Unlock Forecast - 30 Days FREE Trial $13952M 17,4x 1,8x
RITM-PD Unlock Forecast - 30 Days FREE Trial $13746M 17,1x 1,7x
RLJ Unlock Forecast - 30 Days FREE Trial $1158M 20,0x 0,5x
RLJ-PA Unlock Forecast - 30 Days FREE Trial $3755M 65,0x 1,7x
ROIC Unlock Forecast - 30 Days FREE Trial $2248M 45,7x 1,7x
RPT Unlock Forecast - 30 Days FREE Trial $129M -0,8x 0,4x
RWT Unlock Forecast - 30 Days FREE Trial $17M 31,3x 0,0x
RWTN Unlock Forecast - 30 Days FREE Trial $70M x 0,1x
RWTO Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RWTP Unlock Forecast - 30 Days FREE Trial $69M x 0,1x
RYN Unlock Forecast - 30 Days FREE Trial $3676M 36,4x 1,9x
SACC Unlock Forecast - 30 Days FREE Trial $1174M 370,5x 5,3x
SACH Unlock Forecast - 30 Days FREE Trial $54M 21,3x 0,3x
SAFE Unlock Forecast - 30 Days FREE Trial $1189M 11,6x 0,5x
SBAC Unlock Forecast - 30 Days FREE Trial $20387M 23,2x -5,1x
SBRA Unlock Forecast - 30 Days FREE Trial $4619M 25,3x 1,7x
SCCC Unlock Forecast - 30 Days FREE Trial $1183M 361,5x 6,6x
SCCD Unlock Forecast - 30 Days FREE Trial $1029M 304,5x 5,7x
SCCE Unlock Forecast - 30 Days FREE Trial $923M 304,8x 5,1x
SCCF Unlock Forecast - 30 Days FREE Trial $907M 279,9x 5,1x
SCCG Unlock Forecast - 30 Days FREE Trial $911M 325,2x 5,1x
SELF Unlock Forecast - 30 Days FREE Trial $60M 24,0x 1,3x
SEVN Unlock Forecast - 30 Days FREE Trial $163M 10,5x 0,6x
SILA Unlock Forecast - 30 Days FREE Trial $1360M x 1,0x
SITC Unlock Forecast - 30 Days FREE Trial $495M 1,4x 1,0x
SKT Unlock Forecast - 30 Days FREE Trial $4084M 38,7x 6,4x
SLG Unlock Forecast - 30 Days FREE Trial $4965M -33,2x 1,3x
SLG-PI Unlock Forecast - 30 Days FREE Trial $1889M x 0,5x
SOHO Unlock Forecast - 30 Days FREE Trial $18M -1,4x 0,4x
SOHOB Unlock Forecast - 30 Days FREE Trial $322M -21,4x 7,0x
SOHON Unlock Forecast - 30 Days FREE Trial $335M -21,8x 7,3x
SOHOO Unlock Forecast - 30 Days FREE Trial $333M -25,6x 7,2x
SPG Unlock Forecast - 30 Days FREE Trial $142M 23,1x 0,1x
SQFT Unlock Forecast - 30 Days FREE Trial $64M 1,2x 1,8x
SQFTP Unlock Forecast - 30 Days FREE Trial $191M 24,7x 5,4x
SQFTW Unlock Forecast - 30 Days FREE Trial $0M x 0,0x
STAG Unlock Forecast - 30 Days FREE Trial $6992M 29,9x 2,0x
STLY Unlock Forecast - 30 Days FREE Trial $20M 32,3x 0,5x
STRW Unlock Forecast - 30 Days FREE Trial $663M 111,4x 42,8x
STSR Unlock Forecast - 30 Days FREE Trial $28M x 0,4x
STWD Unlock Forecast - 30 Days FREE Trial $7822M 21,2x 1,2x
SUI Unlock Forecast - 30 Days FREE Trial $17201M 13,4x 2,3x
SUNS Unlock Forecast - 30 Days FREE Trial $145M 14,5x 0,8x
SVC Unlock Forecast - 30 Days FREE Trial $481M -2,2x 0,7x
TCI Unlock Forecast - 30 Days FREE Trial $412M 62,5x 0,5x
TFSA Unlock Forecast - 30 Days FREE Trial $202M x 0,0x
TPTA Unlock Forecast - 30 Days FREE Trial $563M x 3,3x
TRTX Unlock Forecast - 30 Days FREE Trial $790M 11,8x 0,7x
TRTX-PC Unlock Forecast - 30 Days FREE Trial $1477M 22,0x 1,4x
TWO Unlock Forecast - 30 Days FREE Trial $1289M -55,6x 0,6x
TWOD Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PA Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PB Unlock Forecast - 30 Days FREE Trial $M x x
TWO-PC Unlock Forecast - 30 Days FREE Trial $M x x
UDR Unlock Forecast - 30 Days FREE Trial $16559M 125,5x 5,0x
UHT Unlock Forecast - 30 Days FREE Trial $574M 32,0x 3,5x
UMH Unlock Forecast - 30 Days FREE Trial $1287M 42,2x 1,4x
UMH-PD Unlock Forecast - 30 Days FREE Trial $1924M 63,1x 2,1x
UNIT Unlock Forecast - 30 Days FREE Trial $1760M 49,9x -0,5x
VICI Unlock Forecast - 30 Days FREE Trial $35750M 13,0x 1,3x
VNO Unlock Forecast - 30 Days FREE Trial $9411M 10,8x 1,5x
VNO-PL Unlock Forecast - 30 Days FREE Trial $4291M 4,9x 0,7x
VNO-PM Unlock Forecast - 30 Days FREE Trial $4233M 4,8x 0,7x
VNO-PN Unlock Forecast - 30 Days FREE Trial $4226M 4,8x 0,7x
VNO-PO Unlock Forecast - 30 Days FREE Trial $3528M 4,0x 0,6x
VNORP Unlock Forecast - 30 Days FREE Trial $12723M 14,5x 2,1x
VRE Unlock Forecast - 30 Days FREE Trial $1849M -32,8x 1,7x
VTR Unlock Forecast - 30 Days FREE Trial $31976M 167,2x 2,8x
WELL Unlock Forecast - 30 Days FREE Trial $114326M 101,2x 3,2x
WHLR Unlock Forecast - 30 Days FREE Trial $-9M -4,1x -0,7x
WHLRD Unlock Forecast - 30 Days FREE Trial $-193M -86,0x -4,8x
WHLRL Unlock Forecast - 30 Days FREE Trial $-774M -344,1x -21,2x
WHLRP Unlock Forecast - 30 Days FREE Trial $-22M -9,8x -0,6x
WPC Unlock Forecast - 30 Days FREE Trial $14903M 44,4x 1,8x
WSR Unlock Forecast - 30 Days FREE Trial $693M 20,6x 1,6x
WY Unlock Forecast - 30 Days FREE Trial $18820M 67,5x 2,0x

Perguntas mais frequentes - W. P. Carey Inc. Previsão de acções

Qual é a precisão das previsões de acções W. P. Carey Inc.?

Our AI model demonstrates 59% historical accuracy for WPC predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

Que factores influenciam as previsões W. P. Carey Inc. do preço das acções?

A nossa análise tem em conta os indicadores financeiros de W. P. Carey Inc., as tendências do sector Real Estate & Construction, o sentimento do mercado, os indicadores técnicos, os dados relativos aos resultados e os factores macroeconómicos que afectam o desempenho das acções.

O W. P. Carey Inc. é um bom investimento em 2025?

Com base na nossa análise de IA, W. P. Carey Inc. mostra potencial para vários cenários de mercado. Considere a sua tolerância ao risco, o calendário de investimento e a diversificação da carteira antes de tomar decisões de investimento.

Com que frequência são actualizadas as previsões W. P. Carey Inc.?

As previsões de acções W. P. Carey Inc. são actualizadas diariamente com base em dados de mercado em tempo real, garantindo que recebe as previsões mais actuais baseadas em IA e informações de investimento.

Pretende uma análise W. P. Carey Inc. mais avançada?

Desbloqueie funcionalidades premium, incluindo objectivos de preço detalhados, avaliações de risco, otimização da carteira e alertas em tempo real para as acções W. P. Carey Inc..

🎯 Obter análise Premium 📊 Explorar mais acções

O meu portefólio

Painel de controlo do investimento

Carregar a sua carteira...